5QJ2 | pdb_00005qj2

CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) OMPLEX WITH COMPOUND-20 AKA 7-((3-(1-METHYL-1H-PYRAZOL-3- YL)BENZYL)OXY)- 1H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN-5-AMINE


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.82 Å
  • R-Value Free: 
    0.272 (Depositor), 0.288 (DCC) 
  • R-Value Work: 
    0.206 (Depositor), 0.218 (DCC) 
  • R-Value Observed: 
    0.210 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 5QJ2

Ligand Structure Quality Assessment 


This is version 1.4 of the entry. See complete history

Literature

Potent Triazolopyridine Myeloperoxidase Inhibitors.

Wurtz, N.R.Viet, A.Shaw, S.A.Dilger, A.Valente, M.N.Khan, J.A.Jusuf, S.Narayanan, R.Fernando, G.Lo, F.Liu, X.Locke, G.A.Kopcho, L.Abell, L.M.Sleph, P.Basso, M.Zhao, L.Wexler, R.R.Duclos, F.Kick, E.K.

(2018) ACS Med Chem Lett 9: 1175-1180

  • DOI: https://doi.org/10.1021/acsmedchemlett.8b00308
  • Primary Citation Related Structures: 
    5QJ2, 5QJ3

  • PubMed Abstract: 

    Myeloperoxidase (MPO) generates reactive oxygen species that potentially contribute to many chronic inflammatory diseases. A recently reported triazolopyrimidine MPO inhibitor was optimized to improve acid stability and remove methyl guanine methyl transferase (MGMT) activity. Multiple synthetic routes were explored that allowed rapid optimization of a key benzyl ether side chain. Crystal structures of inhibitors bound to the MPO active site demonstrated alternate binding modes and guided rational design of MPO inhibitors. Thioether 36 showed significant inhibition of MPO activity in an acute mouse inflammation model after oral dosing.


  • Organizational Affiliation
    • Bristol-Myers Squibb Research and Development, P.O. Box 5400, Princeton, New Jersey 08534, United States.

Macromolecule Content 

  • Total Structure Weight: 272.4 kDa 
  • Atom Count: 18,513 
  • Modeled Residue Count: 2,272 
  • Deposited Residue Count: 2,288 
  • Unique protein chains: 2

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
MyeloperoxidaseA,
C [auth D],
E [auth F],
G [auth H]
105Homo sapiensMutation(s): 0 
EC: 1.11.2.2
UniProt & NIH Common Fund Data Resources
Find proteins for P05164 (Homo sapiens)
Explore P05164 
Go to UniProtKB:  P05164
PHAROS:  P05164
GTEx:  ENSG00000005381 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP05164
Sequence Annotations
Expand
Reference Sequence
Find similar proteins by:|  3D Structure
Entity ID: 2
MoleculeChains  Sequence LengthOrganismDetailsImage
MyeloperoxidaseB,
D [auth E],
F [auth G],
H [auth I]
467Homo sapiensMutation(s): 0 
EC: 1.11.2.2
UniProt & NIH Common Fund Data Resources
Find proteins for P05164 (Homo sapiens)
Explore P05164 
Go to UniProtKB:  P05164
PHAROS:  P05164
GTEx:  ENSG00000005381 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP05164
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 8 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
HEM

Query on HEM



Download:Ideal Coordinates CCD File
FA [auth E],
FB [auth I],
OA [auth G],
P [auth B]
PROTOPORPHYRIN IX CONTAINING FE
C34 H32 Fe N4 O4
KABFMIBPWCXCRK-RGGAHWMASA-L
JXS

Query on JXS



Download:Ideal Coordinates CCD File
GA [auth E],
TA [auth G],
U [auth B]
7-{[3-(1-methyl-1H-pyrazol-3-yl)phenyl]methoxy}-1H-[1,2,3]triazolo[4,5-b]pyridin-5-amine
C16 H15 N7 O
WGMJNFFLMIILAZ-UHFFFAOYSA-N
NAG

Query on NAG



Download:Ideal Coordinates CCD File
AA [auth E]
AB [auth I]
BA [auth E]
BB [auth I]
CA [auth E]
AA [auth E],
AB [auth I],
BA [auth E],
BB [auth I],
CA [auth E],
CB [auth I],
DA [auth E],
DB [auth I],
I [auth B],
IA [auth G],
J [auth B],
JA [auth G],
K [auth B],
KA [auth G],
L [auth B],
LA [auth G],
M [auth B],
NA [auth G],
O [auth B],
PA [auth G],
Q [auth B],
WA [auth I]
2-acetamido-2-deoxy-beta-D-glucopyranose
C8 H15 N O6
OVRNDRQMDRJTHS-FMDGEEDCSA-N
MAN

Query on MAN



Download:Ideal Coordinates CCD File
RA [auth G]
S [auth B]
SA [auth G]
T [auth B]
Y [auth E]
RA [auth G],
S [auth B],
SA [auth G],
T [auth B],
Y [auth E],
YA [auth I],
Z [auth E],
ZA [auth I]
alpha-D-mannopyranose
C6 H12 O6
WQZGKKKJIJFFOK-PQMKYFCFSA-N
BMA

Query on BMA



Download:Ideal Coordinates CCD File
QA [auth G],
R [auth B],
X [auth E],
XA [auth I]
beta-D-mannopyranose
C6 H12 O6
WQZGKKKJIJFFOK-RWOPYEJCSA-N
FUC

Query on FUC



Download:Ideal Coordinates CCD File
EA [auth E],
EB [auth I],
MA [auth G],
N [auth B]
alpha-L-fucopyranose
C6 H12 O5
SHZGCJCMOBCMKK-SXUWKVJYSA-N
CA

Query on CA



Download:Ideal Coordinates CCD File
GB [auth I],
HA [auth E],
UA [auth G],
V [auth B]
CALCIUM ION
Ca
BHPQYMZQTOCNFJ-UHFFFAOYSA-N
CL

Query on CL



Download:Ideal Coordinates CCD File
VA [auth G],
W [auth B]
CHLORIDE ION
Cl
VEXZGXHMUGYJMC-UHFFFAOYSA-M

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.82 Å
  • R-Value Free:  0.272 (Depositor), 0.288 (DCC) 
  • R-Value Work:  0.206 (Depositor), 0.218 (DCC) 
  • R-Value Observed: 0.210 (Depositor) 
Space Group: C 2 2 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 143.817α = 90
b = 150.949β = 90
c = 233.104γ = 90
Software Package:
Software NamePurpose
XDSdata reduction
SCALAdata scaling
PHASERphasing
BUSTERrefinement
PDB_EXTRACTdata extraction

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

  • Released Date: 2019-02-06 
  • Deposition Author(s): Khan, J.A.

Revision History  (Full details and data files)

  • Version 1.0: 2019-02-06
    Type: Initial release
  • Version 1.1: 2020-07-29
    Type: Remediation
    Reason: Carbohydrate remediation
    Changes: Data collection, Derived calculations, Structure summary
  • Version 1.2: 2021-05-12
    Changes: Structure summary
  • Version 1.3: 2024-10-09
    Changes: Advisory, Data collection, Database references, Structure summary
  • Version 1.4: 2026-02-18
    Changes: Refinement description